4.8 Article

A self-monitoring microneedle patch for light-controlled synergistic treatment of melanoma

Journal

BIOACTIVE MATERIALS
Volume 27, Issue -, Pages 58-71

Publisher

KEAI PUBLISHING LTD
DOI: 10.1016/j.bioactmat.2023.03.016

Keywords

Microneedle; Controlled release; Melanoma; AIE; Photothermal therapy; Chemotherapy

Ask authors/readers for more resources

Melanoma, the most aggressive form of skin cancer, is difficult to treat due to frequent drug administration and lack of direct monitoring of drug release. In this study, a self-monitoring microneedle-based drug delivery system was developed for light-controlled chemo-photothermal therapy of melanoma. The system utilized PATC microparticles that encapsulate both a chemotherapeutic drug and a photothermal agent, allowing for direct observation and verification of drug release under light stimuli.
Melanoma is the most aggressive and malignant form of skin cancer. Current melanoma treatment methods generally suffer from frequent drug administration as well as difficulty in direct monitoring of drug release. Here, a self-monitoring microneedle (MN)-based drug delivery system, which integrates a dissolving MN patch with aggregation-induced emission (AIE)-active PATC microparticles, is designed to achieve light-controlled pulsatile chemo-photothermal synergistic therapy of melanoma. The PATC polymeric particles, termed D/I@PATC, encapsulate both of chemotherapeutic drug doxorubicin (DOX) and the photothermal agent indocyanine green (ICG). Upon light illumination, PATC gradually dissociates into smaller particles, causing the release of encapsulated DOX and subsequent fluorescence intensity change of PATC particles, thereby not only enabling direct observation of the drug release process under light stimuli, but also facilitating verification of drug release by fluorescence recovery after light trigger. Moreover, encapsulation of ICG in PATC particles displays significant improvement of its photothermal stability both in vitro and in vivo. In a tumor-bearing mouse, the application of one D/I@PATC MN patch combining with two cycles of light irradiation showed excellent controllable chemophotothermal efficacy and exhibited similar to 97% melanoma inhibition rate without inducing any evident systemic toxicity, suggesting a great potential for skin cancer treatment in clinics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available